DOCSLIB.ORG

Pediatric Gastroenterology Subdivisions of Core Area

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Pediatric Gastroenterology Subdivisions of Core Area SALZBURG CHOP SEMINARS Pediatrics – 3-Year Curriculum YEAR 1 (2018, 2021, 2024, etc.) Module I Core Area: Behavioral Pediatrics and Child Development Subdivisions of Core Area: 1. Prematurity: Impact on Development and Behavior 2. Cerebral Palsy: Diagnosis and Treatment 3. Autism Spectrum Disorders (ASD): Overview and Diagnosis 4. Autism Spectrum Disorders (ASD) Treatment and Controversies 5. Complementary & Alternative Medical (CAM) Treatments in Developmental Disabilities 6. Mood and Anxiety Disorders 7. Workshop: Diagnostic Dilemmas (Fellows Case Presentations) 8. Principles of Developmental and Behavioral Pediatrics 9. Screening and Developmental Assessment 10. Developmental Delay and Intellectual Disability 11. Sleep Disruptions and Disorders 12. Elimination Disorders 13. Workshop Case Presentations by Faculty to Fellows 14. Language and Learning Disorders 15. Sensory Impairment: Visual and Hearing Loss 16. Attention-Deficit Hyperactivity Disorders (ADHD) Diagnosis and Treatment 17. Psychopharmacology for Children with Developmental Disabilities 18. Early Infant Development 19. Genetic Disorder and Associated Developmental Disabilities 20. Down Syndrome 21. Behavioral Management-Part I and Part II Module II Core Area: Pediatric Cardiology Subdivisions of Core Area: 1. Introduction to Congenital Heart Diseases 2. Diagnostic Catheterization 3. Pediatric Echocardiography 4. Assessment and Treatment of Rhythm Abnormalities 5. Shunt Lesions (ASD, VSD, and more) 6. Catheter-Based and Surgical Therapies for Shunt Lesions 7. Tetralogy of Fallot & Truncus Arteriosus 8. Pulmonary Atresia/Intact Ventricular Septum 9. Fetal Cardiology 10. Management of Heart Disease in the Fetus 11. Single Ventricle Heart Defects in the Neonate 12. Fontan Physiology: Short & Long-Term Outcome 13. Tricuspid & Mitral Valve Abnormalities 14. Chest Pain & Syncope 15. Cardiovascular Risk Assessment in Children 16. Adult Congenital Heart Disease 17. Aortic Valve & Arch Anomalies 18. Coronary Artery Anomalies 19. Pulmonary Hypertension 20. Cardiomyopathy 21. Cardiac MRI Module III Core Area: General Pediatrics Subdivisions of Core Area: 1. TBA Module IV Core Area: Pediatric Radiology Subdivisions of Core Area: 1. Imaging of Common Pediatric Musculoskeletal Diseases 2. Imaging of Normal Anatomy & Variants 3. Imaging of Trauma, Child Abuse & Infections 4. Imaging of Tumors with a Focus on Radiographs, CT and MRI 5. Systematic Review of the Interpretation of X-Rays in Children with Cyanotic and Acyanotic Heart Diseases 6. How to Perform and Interpret Cardiac CT 7. Introduction to Cardiac MRI 8. Systematic Approach to Cong Heart Disease 9. Cong Heart Disease Role of CXR 10. CMRI & cCT Basics and Pitfalls 11. Imaging of Pulmonary Hypertension 12. Cardiac CT Made Simple: How I Do It 13. Radiology of the Battered Child Syndrome 14. Common Fractures: The Child Who Falls 15. Normal Pediatric Skeleton & Mimickers of Disease 16. Bone Infections 17. Upper Extremity Trauma 18. Lower Extremity Trauma 19. Developmental Abnormalities of the Hip and Shoulder 20. Benign Bone Tumors 21. Malignant Bone Tumors 22. MSK Ultrasound 23. Imaging of Arthritis: Multimodality Approach Module V Core Area: Neonatology Subdivisions of Core Area: 1. Neonatal Jaundice 2. Limits of Viability 3. Late Preterm 4. Neonatal Shock 5. HIE/Cooling 6. Neonatal Nutrition 7. Parenteral Nutrition 8. NEC 9. Sepsis/Nosocomial Infections 10. ROP 11. Quality Measures 12. Physiology of Neonatal Transition 13. Neonatal Seizures / Amplitude-integrated EEG [aEEG] 14. Oxygen Use in the NICU 15. PPHN 16. RDS 17. Lung Protective Ventilation to Prevent BPD Module VI Core Area: Pediatric Urology Subdivisions of Core Area: 1. TBA YEAR 2 (2019, 2022, 2025, etc.) Module VII Core Area: Pediatric Pulmonology Subdivisions of Core Area: 1. Cystic Fibrosis 2. RSV/ Bronchiolitis 3. Chronic lung Disease of Infancy 4. Sleep Disorders 5. Pulmonary Function Testing: Infant, Pre-School 6. Pulmonary Function Testing: Older Children and Adult 7. Non-Invasive Ventilation 8. Pulmonary Complications of Neuromuscular Disorders: Asthma- Pulmonology Perspective 9. Asthma-Allergy Perspective 10. Physiology-Clinical Applications 11. Congenital Lung Disorders 12. Exercise Testing/ 6 Minute Walk Test 13. Lung Transplantation 14. Noisy Breathing 15. Recurrent Pneumonia 16. Interstitial Lung Disease 17. Allergy 18. Chest Physiotherapy Module VIII Core Area: Pediatric Anesthesiology Subdivisions of Core Area: 1. Circulatory Shock 2. Septic Shock 3. Acute Lung Injury 4. Advanced Ventilatory Strategies 5. ECMO 6. Cardiac Arrest and Resuscitation 7. Ventilator-Associated Pneumonia 8. Deep Vein Thrombosis 9. Quality and Safety in the PICU 10. Brain Death 11. 2010 PALS Guideline Changes 12. Renal Replacement Therapies 13. Traumatic Brain Injury 14. Nosomial Infections in the PICU 15. Pulmonary Hypertension 16. Burns Module IX Core Area: Pediatric Neurology Subdivisions of Core Area: 1. Tutorial on Pediatric Electroencephalography 2. Neurogenetics: Neuromuscular Disease, Mental Retardation, Diseases that Affect Neurotransmitter Synthesis 3. Head Trauma and Management of Increased Intracranial Pressure 4. Childhood Cerebrovascular Disease 5. Pediatric Multiple Sclerosis Module X Core Area: Pediatric Emergency Medicine Subdivisions of Core Area: 1. Emergency Airway Management 2. Respiratory Emergencies 3. Management of Shock 4. Evaluation of Febrile Children 5. Seizures 6. Abdominal Pain 7. Acute Multisystem Trauma & Minor Trauma 8. Orthopedics 9. Radiology Module XI Core Area: Pediatric Gastroenterology Subdivisions of Core Area: 1. Celiac Disease 2. Gastroesophageal reflux 3. Eosinophilic Esophagitis 4. Inflammatory Bowel Disease 5. Constipation 6. Gastrointestinal Bleeding 7. Gastrointestinal Technology (Endoscopy, Manometry, Video Capsule, Bleeding Intervention) 8. Neonatal Jaundice 9. Liver Failure 10. Cystic Fibrosis 11. Malabsorption 12. Food Allergy 13. Pathology of the Gastrointestinal Tract 14. Foreign Bodies 15. Viral Hepatitis 16. Metabolic Liver Disease 17. Gastrointestinal Polyps 18. Cyclic Vomiting 19. Short Gut 20. Pancreatitis 21. Fatty Liver Module XII Core Area: Pediatric Orthopedics Subdivisions of Core Area: 1. TBA YEAR 3 (2020, 2023, 2026, etc.) Module XIII Core Area: Pediatric Infectious Diseases Subdivisions of Core Area: 1. Infections Due to Unusual and Antibiotic-Resistant Organisms 2. Infections in Vulnerable Patient Populations 3. Prevention of Healthcare-Associated Infections 4. Vaccines and Vaccine-Preventable Diseases Module XIV Core Area: Pediatric Immunology Subdivisions of Core Area: 1. Anaphylaxis 2. Atopic Dermatitis: Pathogenesis and Management 3. Atopic Dermatitis and Immunodeficiency 4. Hematopoietic Stem Cell Transplantation: Expanding Use in Immunodeficiency 5. Testing for Environmental Allergens 6. Food Allergy Review: IgE Mediated & Non-IgE Mediated. 7. State of the Art in Food Allergy Therapies 8. Overview of Eosinophilic Esophagitis 9. Immunology Overview 10. Disorders of Adaptive Immunity 11. Disorders of Innate Immunity 12. Immunodeficiency Cases 13. Wheezing in Preschool Children 14. Management of Chronic Asthma: Review of Guidelines 15. Management of Difficult to Control Asthma 16. Spirometry in Children 17. Allergy: Epidemic of the 21st Century? 18. Allergen Immunotherapy in Children: The European Viewpoint 19. Venom Allergy in Children 20. Urticaria in Children: Need for a Pediatric Allergist Module XV Core Area: Pediatric Emergency Medicine Subdivisions of Core Area: 1. Pediatric Advanced Life Support 2. Emergency Management of the Pediatric Airway 3. Sepsis and Shock in Children 4. Asthma 5. Hypertensive Emergencies 6. Head Trauma in Children 7. Cervical Spine Injuries in Children 8. Abdominal Pain in Children and Adolescents 9. Seizures and Febrile Seizures in Children 10. Diabetic Ketoacidosis 11. Approach to Young Children with Fever 12. Urinary Tract Infections 13. Methemoglobinemia 14. Approach to Children with Heat Illness 15. Pediatric Eye Emergencies including Trauma 16. Gastrointestinal Foreign Bodies 17. Procedural Sedation and Analgesia 18. Drowning and Submersion Injuries 19. Tips of the Trade: Minor Procedures in the ED 20. Approach to Toxicological Emergencies 21. Child Abuse and Sexual Assault 22. Care of the Technology Dependent Child 23. The Year in Review: Impact Articles in PEM 2013 24. Simulation Exercises with High Fidelity Patient Simulators Module XVI Core Area: Pediatric Hematology/ Oncology Subdivisions of Core Area: 1. Acute Lymphoblastic Leukemia 2. Acute Myelogenous Leukemia 3. Lymphoma 4. Palliative Care 5. Brain Tumors 6. Approach to Anemia 7. Bone Marrow Failure 8. Transfusion Therapy/ Iron Overload 9. Hemophilia and Bleeding Disorders 10. Thrombosis 11. ITP and Platelet Disorders 12. Malignant Bone Tumors 13. Malignant Soft Tissue Tumors 14. Neuroblastoma 15. Nephroblastoma 16. Bone Marrow Transplant Module XVII Core Area: Pediatric Endocrinology/ Nephrology Subdivisions of Core Area 1. Primary Hypertension/ Obesity 2. Secondary Hypertension 3. SLE/ Vasculitis 4. Transplantation 5. Glomerulonephritis 6. AKI 7. CDK/Dialysis 8. Tubular Disorders 9. Urinary Tract Infections 10. Obstructive Uropathy 11. Nephrotic Syndrome 12. Nephrolithiasis 13. Infection-Induced HUS 14. Non-Infection-Induced HUS 15. Renal Anemia 16. Growth Disorders 17. Disorders of Puberty 18. Thyroid Disorders 19. Pituitary Disease 20. Late Effects in Cancer Survivors 21. Adrenal Disease .
Load more

Recommended publications
  • Internal Medicine – Focus on Pediatrics/Neonatology Learning Experience 1 & 2
    CONTROLLED UNLESS PRINTED PGY1 – Internal Medicine – Focus on Pediatrics/Neonatology Learning Experience 1 & 2 Preceptors* Emily Siegrist, PharmD ([email protected]) Deanna Dickson, PharmD ([email protected]) Elaine Rietmann, PharmD ([email protected]) Hours: 0700 to 1730 *Primary preceptors and preceptors will be assigned dependent on pharmacist schedule during rotation General Description This rotation is concentrated in four weeks of exposure to the pediatric and neonatal populations at Asante Rogue Regional Medical Center. The clinical pharmacist on the team is responsible for ensuring safe and effective medication use for all patients admitted to the pediatric and neonatal intensive care unit. Routine responsibilities include: review and confirmation of appropriateness of medication for the patient population based upon age, weight, indication and pharmacokinetic considerations; completion of consults and medication therapy protocols in areas including dosing and monitoring of TPN, kinetics, evaluation of anti-infectives, addressing formal consults for non-formulary drug requests and providing patient and family education. The pharmacist also provides drug information and education to healthcare professionals as requested. Expectations of the Resident Residents will attend NICU and Pediatric rounds every day. During this rotation the resident will focus on caring for patients in the pediatric and neonatal intensive care units. Residents will actively seek to identify the potential for significant medication-related
    [Show full text]
  • Study Guide Medical Terminology by Thea Liza Batan About the Author
    Study Guide Medical Terminology By Thea Liza Batan About the Author Thea Liza Batan earned a Master of Science in Nursing Administration in 2007 from Xavier University in Cincinnati, Ohio. She has worked as a staff nurse, nurse instructor, and level department head. She currently works as a simulation coordinator and a free- lance writer specializing in nursing and healthcare. All terms mentioned in this text that are known to be trademarks or service marks have been appropriately capitalized. Use of a term in this text shouldn’t be regarded as affecting the validity of any trademark or service mark. Copyright © 2017 by Penn Foster, Inc. All rights reserved. No part of the material protected by this copyright may be reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, or by any information storage and retrieval system, without permission in writing from the copyright owner. Requests for permission to make copies of any part of the work should be mailed to Copyright Permissions, Penn Foster, 925 Oak Street, Scranton, Pennsylvania 18515. Printed in the United States of America CONTENTS INSTRUCTIONS 1 READING ASSIGNMENTS 3 LESSON 1: THE FUNDAMENTALS OF MEDICAL TERMINOLOGY 5 LESSON 2: DIAGNOSIS, INTERVENTION, AND HUMAN BODY TERMS 28 LESSON 3: MUSCULOSKELETAL, CIRCULATORY, AND RESPIRATORY SYSTEM TERMS 44 LESSON 4: DIGESTIVE, URINARY, AND REPRODUCTIVE SYSTEM TERMS 69 LESSON 5: INTEGUMENTARY, NERVOUS, AND ENDOCRINE S YSTEM TERMS 96 SELF-CHECK ANSWERS 134 © PENN FOSTER, INC. 2017 MEDICAL TERMINOLOGY PAGE III Contents INSTRUCTIONS INTRODUCTION Welcome to your course on medical terminology. You’re taking this course because you’re most likely interested in pursuing a health and science career, which entails ­proficiency­in­communicating­with­healthcare­professionals­such­as­physicians,­nurses,­ or dentists.
    [Show full text]
  • How to Recognize a Suspected Cardiac Defect in the Neonate
    Neonatal Nursing Education Brief: How to Recognize a Suspected Cardiac Defect in the Neonate https://www.seattlechildrens.org/healthcare- professionals/education/continuing-medical-nursing-education/neonatal- nursing-education-briefs/ Cardiac defects are commonly seen and are the leading cause of death in the neonate. Prompt suspicion and recognition of congenital heart defects can improve outcomes. An ECHO is not needed to make a diagnosis. Cardiac defects, congenital heart defects, NICU, cardiac assessment How to Recognize a Suspected Cardiac Defect in the Neonate Purpose and Goal: CNEP # 2092 • Understand the signs of congenital heart defects in the neonate. • Learn to recognize and detect heart defects in the neonate. None of the planners, faculty or content specialists has any conflict of interest or will be presenting any off-label product use. This presentation has no commercial support or sponsorship, nor is it co-sponsored. Requirements for successful completion: • Successfully complete the post-test • Complete the evaluation form Date • December 2018 – December 2020 Learning Objectives • Describe the risk factors for congenital heart defects. • Describe the clinical features of suspected heart defects. • Identify 2 approaches for recognizing congenital heart defects. Introduction • Congenital heart defects may be seen at birth • They are the most common congenital defect • They are the leading cause of neonatal death • Many neonates present with symptoms at birth • Some may present after discharge • Early recognition of CHD
    [Show full text]
  • OTITIS MEDIA (OM): a COMMON COMPLICATION OFNASOTRACH- AMNIOTIC Nuid - DIAGNOSIS USING B2 MICROGLOBULIN
    NEONATOLOGY TUBULAR DYSFUNCTION IN INFANTS WITH MECONIUM STAINED OTITIS MEDIA (OM): A COMMON COMPLICATION OFNASOTRACH- AMNIOTIC nUID - DIAGNOSIS USING B2 MICROGLOBULIN. EAL INTUBATION (NTI) IN THE NEONATE. Janet Purn, Ilana t 1469 Ronald J.Portman, Jennifer W.Cole, Jeffrey M.Perlman, 1472 Zarafu, (Spon. Franklin C. Behrle) Univ. of Medicine Yin Lim, Alan M.Robson, Washington Univ. Sch. of Med., St.Louis and Dentistry: New Jersey Medical School, Newark Beth Israel Med- Children's Hospital, Department of Pediatrics, St.Louis, MO ical Center (NBIMC) Dept. of Peds., Newark, N. J. 07112 Urinary concentrations of B2 microglobulin (B2M) and creatin- Auditory Brainstem Responses (ABR) are recorded in the Newborn ine were measured in normal term infants and in those born with Special Care Center at NBIMC prior to discharge.From 9/82 to 8/83 meconium stained amniotic fluid (MEC). None of the infants or 252 infants (INFS) had ABR evaluations. One hundred one INFS were their mothers had conditions known to modify B2M excretion. Apgar ventilated through endotracheal tube. They were assessed by ABR scores for the normal and MEC infants averaged 8.8 and 7.7 re- and otoscopy~ta mean postnatal age of 39 days (D). The mean spectively at 1 min and 9.0 and 8.2 at 5 min. Urinary B2M to cre- birthweight (BW) of intubated INFS was 1895gms (580-4170), and mean atinine levels (mglgm) increased significantly (~<.01)in the duration of intubation was 5.8 D. NTI was used in 98 INFS,oral in- normal infants from day 1 (1.5+1.3:n=29) to day 3 (3.5+2.B:n=21) tubation in 3 and 18 had NTI and oral tubes.
    [Show full text]
  • Eric D. Schultz, DO, MPH
    Eric D. Schultz, DO, MPH EDUCATION 07/2005-06/2008 Duke University Medical Center Durham, NC Neonatal-Perinatal Intensive Care Fellowship 07/2002-06/2005 University of California, Irvine Orange, CA Pediatric Residency 08/1998-06/2002 Western University of Health Sciences Pomona, CA D.O. 08/1993-05/1996 California State University, San Diego San Diego, CA M.P.H.: Epidemiology 09/1988-06/1993 University of California, San Diego La Jolla, CA B.A.: Chemistry/Biochemistry PROFESSIONAL EXPERIENCE 03/2011 – Present Texas A & M College of Medicine Round Rock, TX Clinical Assistant Professor: Dept. of Pediatrics 09/2010 – Present Greater Austin Allergy, Asthma & Immunology Austin, TX Allergy, Asthma and Immunology Physician 09/2010 – 09/2016 Sneeze Allergy, Cough and Sinus Centers Austin, TX Chief Medical Officer AN EXPERT APPROACH TO ALLERGY RELIEFSM • AUSTINALLERGIST.COM 06/2010 – 09/2010 Pediatric Subspecialty Faculty Orange, CA Associate Director of Neonatal-Perinatal Education 04/2010 – 09/2010 University of California, Irvine Orange, CA Clinical Instructor: Division of Neonatology 06/2009 – 09/2010 Children’s Hospital of Orange County Orange, CA Neonatologist 07/2008 – 06/2009 Rady Children’s Hospital of San Diego San Diego, CA Neonatologist 07/2008 – 06/2009 Sharp Mary Birch Hospital San Diego, CA Neonatologist 10/2006 – 06/2008 Columbus Regional Hospital Whiteville, NC Pediatric Hospitalist GRANTS Duke University Medical Center Children’s Miracle Network Grant T32 NIH National Research Service Award AN EXPERT APPROACH TO ALLERGY RELIEFSM • AUSTINALLERGIST.COM CLINICAL TRIALS 2006-2008 Principal Investigator: Duke University. Children’s Miracle Network Grant. Blocking mast cell homing prevents airways hyperreactivity in hyperoxia exposed newborn rats.
    [Show full text]
  • Pulmonary-Atresia-Mapcas-Pavsdmapcas.Pdf
    Normal Heart © 2012 The Children’s Heart Clinic NOTES: Children’s Heart Clinic, P.A., 2530 Chicago Avenue S, Ste 500, Minneapolis, MN 55404 West Metro: 612-813-8800 * East Metro: 651-220-8800 * Toll Free: 1-800-938-0301 * Fax: 612-813-8825 Children’s Minnesota, 2525 Chicago Avenue S, Minneapolis, MN 55404 West Metro: 612-813-6000 * East Metro: 651-220-6000 © 2012 The Children’s Heart Clinic Reviewed March 2019 Pulmonary Atresia, Ventricular Septal Defect and Major Aortopulmonary Collateral Arteries (PA/VSD/MAPCAs) Pulmonary atresia (PA), ventricular septal defect (VSD) and major aortopulmonary collateral arteries (MAPCAs) is a rare type of congenital heart defect, also referred to as Tetralogy of Fallot with PA/MAPCAs. Tetralogy of Fallot (TOF) is the most common cyanotic heart defect and occurs in 5-10% of all children with congenital heart disease. The classic description of TOF includes four cardiac abnormalities: overriding aorta, right ventricular hypertrophy (RVH), large perimembranous ventricular septal defect (VSD), and right ventricular outflow tract obstruction (RVOTO). About 20% of patients with TOF have PA at the infundibular or valvar level, which results in severe right ventricular outflow tract obstruction. PA means that the pulmonary valve is closed and not developed. When PA occurs, blood can not flow through the pulmonary arteries to the lungs. Instead, the child is dependent on a patent ductus arteriosus (PDA) or multiple systemic collateral vessels (MAPCAs) to deliver blood to the lungs for oxygenation. These MAPCAs usually arise from the de- scending aorta and subclavian arteries. Commonly, the pulmonary arteries are abnormal, with hypoplastic (small and underdeveloped) central and branch pulmonary arteries and/ or non-confluent central pulmonary arteries.
    [Show full text]
  • Effects of Severe Hypoxia on Dilator Prostaglandin Synthesis
    NEONATOLOGY 325A MYOINOSITOL SUPPLEMENTATION IN RESPIRATORY DISTRESS THROMBOXANE B LEVEL S IN NEONATES WITH PERSISTENT SYNDROME (RDS). Mikko Hallman, Anna-Liisa FETAL CIRCULAfiON. Cathy Harrunerman, Elene Strates, Pat Bromberger. Childrens' Hosp ital, Univ. Helsinki, Stuart Berger and W1lliam Za1a. (Spon . by K.S. Lee), Fi nland; Univ. California, San Diego, CA . University of Chicago Medical Center, Department of Pedi atrics, Myoinositol (INO) may potentiate hormone-induced lung matura­ Chicago, IL. tion & increase surfactant in lung damage (Ped Re • 17 , 378A,-83; Plasma levels of Thromboxane B2 (TxB 2) were determined by Life Sci 31, 175,-82). Serum INO is high in RDS at birth. INO de­ radioimmunoassay in seven infants with persistent fetal circu la­ creases after bi rth , in part because the diet may contain only tion (PFC) of various etiologies. The levels were found to be little INO. In the present randomized double-blind trial involv­ quite elevated as compared with those of seven neonates with ing 22 RDS cases (BW <2000g), we studied the effect of INO on other cardiorespi ratory problems, but without PFC: serum INO and on lung phospholipids . Either INO or glucose (GLU) MEAN (dose: 1 ml isotonic sugar/kg q 6 h) was given orally for 7 days, PFC 2426 12 2540 585 591 628 331 1016.!:_1025 beginning da y two. The amount of INO was similar to. INO in 200 ml/kg of preterm breast milk. There was no d1fferences 1n Controls 282 34 237 188 99 134 48 146.!:_ 94 BW (1273±57g), GA (29.3±0.4 wks), or severity of RDS during the All of the infants with PFC, except one, had TxB2 levels >300pg/ first 48 h, as compared between the INO and the GLU groups.
    [Show full text]
  • Palliative Care in Critical Perinatal and Neonatal Cardiac Patients
    children Review Redefining the Relationship: Palliative Care in Critical Perinatal and Neonatal Cardiac Patients Natasha S. Afonso 1, Margaret R. Ninemire 1, Sharada H. Gowda 2, Jaime L. Jump 1,3, Regina L. Lantin-Hermoso 4, Karen E. Johnson 2, Kriti Puri 1, Kyle D. Hope 4, Erin Kritz 1, Barbara-Jo Achuff 1, Lindsey Gurganious 3 and Priya N. Bhat 1,* 1 Sections of Critical Care Medicine and Cardiology, Department of Pediatrics, Texas Children’s Hospital and Baylor College of Medicine, Houston, TX 77030, USA; [email protected] (N.S.A.); [email protected] (M.R.N.); [email protected] (J.L.J.); [email protected] (K.P.); [email protected] (E.K.); [email protected] (B.-J.A.) 2 Section of Neonatology, Department of Pediatrics, Texas Children’s Hospital and Baylor College of Medicine, Houston, TX 77030, USA; [email protected] (S.H.G.); [email protected] (K.E.J.) 3 Section of Palliative Care Medicine, Department of Pediatrics, Texas Children’s Hospital and Baylor College of Medicine, Houston, TX 77030, USA; [email protected] 4 Section of Cardiology, Department of Pediatrics, Texas Children’s Hospital and Baylor College of Medicine, Houston, TX 77030, USA; [email protected] (R.L.L.-H.); [email protected] (K.D.H.) * Correspondence: [email protected]; Tel.: +1-832-826-6230; Fax: +1-832-825-4252 Abstract: Patients with perinatal and neonatal congenital heart disease (CHD) represent a unique population with higher morbidity and mortality compared to other neonatal patient groups. Despite Citation: Afonso, N.S.; Ninemire, an overall improvement in long-term survival, they often require chronic care of complex medical M.R.; Gowda, S.H.; Jump, J.L.; illnesses after hospital discharge, placing a high burden of responsibility on their families.
    [Show full text]
  • Moving Neonatology Into the Modern Era of Drug Development
    Moving Neonatology into the Modern Era of Drug Development: Overview of Potential consortium projects and deliverables Mark Turner – University of Liverpool Ron Portman - Novartis Pharmaceuticals Wolfgang Göpel - The German Neonatal Network Stephen Spielberg – Consultant Moving Neonatology into the Modern Era of Drug Development: a clinical perspective Mark Turner Declarations of interest Chair, European Network for Paediatric Research at the European Medicines Agency Publically-funded European Commission FP7, NIHR, BLISS, MRC, AMR • Associate Director (International Liaison) National Institute for Health Research, Children’s Theme • Scientific Coordinator Global Research in Paediatrics (GRiP) Commercial: Pecuniary, non-personal Consultancies Product-specific / National PI: Chiesi, Shire, Non-product-specific: Janssen 3 A clinician’s view of the future Vision Differences from the present Implications for practice 4 Clinical Vision Improved outcomes due to new medicines that come to market rapidly This happens because of: Intelligent pipelines for drug development Smart trials Optimise use of existing data Minimise the impact on babies and families Feasible studies High quality data Line listings, source data verification (SDV) Networks 5 Different approach to most academic neonatal research Regulatory studies canNOT rely on Cochrane Reviews May need to recognise need for different approaches for Pragmatic trials different purposes HTA etc. Examples of differences Need for well-qualified standard of care Justifiable
    [Show full text]
  • Isolated Single Umbilical Artery: Need for Specialist Fetal Echocardiography?
    Ultrasound Obstet Gynecol (2010) Published online in Wiley Online Library (wileyonlinelibrary.com). DOI: 10.1002/uog.7711 Isolated single umbilical artery: need for specialist fetal echocardiography? D. DEFIGUEIREDO, T. DAGKLIS, V. ZIDERE, L. ALLAN and K. H. NICOLAIDES Harris Birthright Research Centre for Fetal Medicine, King’s College Hospital Medical School, London, UK KEYWORDS: cardiac defect; fetal echocardiography; prenatal diagnosis; single umbilical artery; ultrasound ABSTRACT was 33.6% (Table 1)3–15. Consequently, the prenatal diagnosis of SUA should motivate the sonographer to Objective To examine the association between single undertake a systematic and detailed examination of the umbilical artery (SUA) and cardiac defects and to fetal anatomy for the diagnosis or exclusion of associated determine whether patients with SUA require specialist defects. In the reported series of SUA, the prevalence of fetal echocardiography. cardiac defects was 11.4%, but it is not stated whether Methods Incidence and type of cardiac defects were these were isolated or whether they were associated with 3–15 determined in fetuses with SUA detected at routine other, more easily detectable, defects (Table 1) . second-trimester ultrasound examination. In this study we examined the association between SUA and cardiac defects with the aim of determining Results A routine second-trimester scan was performed whether patients with SUA require specialist fetal in 46 272 singleton pregnancies at a median gestation of echocardiography. 22 (range, 18–25) weeks and an SUA was diagnosed in 246 (0.5%). Cardiac defects were diagnosed in 16 (6.5%) of these cases, including 10 (4.3%) in a subgroup of METHODS 233 with no other defects and in six (46.2%) of the 13 with multiple defects.
    [Show full text]
  • World Neonatology, Pediatrics and Developmental Medicine Conference
    2019 Conference Announcement 2020 Journal of Emergency and Internal Medicine Vol.3 No.2 World Neonatology, Pediatrics and Developmental Medicine Conference Leonardo Milella Paediatric Hospital Giovanni XXIII, Italy, E-mail: [email protected] Neonatology deals with the study of medical care of Neonatology Meetings 2020 is being organized to Newborn Infants, especially the ill or premature broaden the scope of the research in the field of newborn. It includes medical diagnosis, treatment & neonatology, perinatology, neonatal intensive care unit prevention of diseases. (NICU), neonatal hepatitis, neonatal genetics, pediatric Conference Series LLC Ltd. is pleased to welcome you to our & neonatal nursing, neonatal CNS disorders, pediatrics World Neonatology, Pediatrics and Developmental Medicine nutrition & metabolism, neonatal & pediatric cardiology, Conference, which is to be held on September 07-08, 2020 at neonatal nutrition & maternal factors, neonatal Prague, Czech Republic. Neonatology Meeting 2020 will be an rheumatology, vaccination & immunization, neonatology inspired and strengthening worldwide gathering reflecting the research, pediatric gastroenterology, pediatric course of Pediatrics in the 21st century in a protected yet endocrinology, maternal & child care, congenital energizing state that offers an extensive variability of malformations & birth complications, and neonatal preoccupations to members of all foundations. This assembly diseases. gives a wonderful chance to talk about the most recent Target Audience: Neonatologists;
    [Show full text]
  • The Outcome of Adults Born with Pulmonary Atresia: High Morbidity and Mortality Irrespective of Repair
    International Journal of Cardiology 280 (2019) 61–66 Contents lists available at ScienceDirect International Journal of Cardiology journal homepage: www.elsevier.com/locate/ijcard The outcome of adults born with pulmonary atresia: High morbidity and mortality irrespective of repair Claudia Montanaro a,1, Assunta Merola a,1, Aleksander Kempny a,b, Belen Alvarez-Alvarez a, Rafael Alonso-Gonzalez a,b, Lorna Swan a,b,AnselmUebinga,b,WeiLia,b, Sonya V. Babu-Narayan a,b, Michael A. Gatzoulis a,b, Konstantinos Dimopoulos a,b,⁎ a Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, Royal Brompton Hospital, London, UK b NIHR Cardiovascular Biomedical Research Unit, Royal Brompton Hospital and National Heart and Lung Institute, Imperial College London, UK article info abstract Article history: Objectives: To describe the characteristics and long-term outcome of a large adult cohort with pulmonary atresia. Received 8 April 2018 Background: Patients with pulmonary atresia (PA) are a heterogeneous population in terms of anatomy, Received in revised form 15 October 2018 physiology and surgical history, and their management during adulthood remains challenging. Accepted 5 November 2018 Methods: Data on all patients with PA followed in our center between January 2000 and March 2015 were Available online 7 November 2018 recorded. Patients were classified into the following groups: PA with ventricular septal defect (PA-VSD, 1), PA with intact ventricular septum (PA-IVS, 2) and other miscellaneous PA (PA-other, 3). Keywords: fi Pulmonary atresia Results: Two-hundred twenty-seven patients with PA were identi ed, 66.1% female, mean age 25.5 ± 8.7 years. Adult Over a median follow-up of 8.8 years, 49 (21.6%) patients had died: heart failure (n = 21, 42.8%) and sudden Outcome cardiac death (n = 8, 16.3%) were the main causes.
    [Show full text]